PROPRANOLOL 40mg. IP + FLUNARIZINE 10mg. IP

Belongs to the class of anti-migraine drugs that are primarily used to treat migraine. Effectively reduces the burden of patients with episodic migraine headaches. (Jeffrey L. Jackson, 2019) Shows significant reduction in the monthly migraine frequency, headache intensity, and headache duration. (Raybarman, 2016) Produces a significant reduction in the number of migraine attacks. (Ludin, 1989) Significantly reduces the severity of attacks and the number of analgesics used during the attacks. (Ludin, 1989) A valuable new treatment choice for patients in whom flunarizine monotherapy is ineffective in migraine prophylaxis. An effective remedy for the prevention of migraine and other headaches. (A Klimek, 1982) A safe and effective candidate for managing migraine headaches. (Srinivasan, 2019) The most preferable prophylactic intervention for reducing headache frequency in migraine patients. (Aijie He, 2017)